Carmichael Hill & Associates, Inc. Abb Vie Inc. Transaction History

Carmichael Hill & Associates, Inc.

$251 Million
Q1 2024

A detailed history of Carmichael Hill & Associates, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Carmichael Hill & Associates, Inc. holds 6,676 shares of ABBV stock, worth $1.09 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

6,676

Previous 6,664 0.18%

Holding current value

$1.09 Million

Previous $1.03 Million 17.73%

% of portfolio

0.48%

Previous 0.43%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$159.82 - $182.1 $1,917 - $2,185	12 Added 0.18%	6,676 $1.22 Million
Q4 2023 Jan 23, 2024	BUY	$137.6 - $154.97 $1,926 - $2,169	14 Added 0.21%	6,664 $1.03 Million
Q3 2023 Oct 30, 2023	BUY	$133.59 - $154.65 $1,736 - $2,010	13 Added 0.2%	6,650 $991,000
Q2 2023 Aug 04, 2023	BUY	$132.51 - $164.9 $160,734 - $200,023	1,213 Added 22.36%	6,637 $894,000
Q1 2023 Apr 05, 2023	BUY	$144.61 - $166.54 $19,377 - $22,316	134 Added 2.53%	5,424 $864,000

Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $414 - $497	-3 Reduced 0.06%	5,290 $855,000
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $1,476 - $1,693	11 Added 0.21%	5,293 $710,000
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $136,381 - $173,385	-991 Reduced 15.8%	5,282 $809,000
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $144,386 - $179,142	1,094 Added 21.12%	6,273 $1.02 Million
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $3,867 - $4,893	36 Added 0.7%	5,179 $701,000
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $1,276 - $1,449	12 Added 0.23%	5,143 $555,000
Q2 2021 Aug 03, 2021	BUY	$105.21 - $117.21 $2,209 - $2,461	21 Added 0.41%	5,131 $578,000
Q1 2021 Apr 28, 2021	BUY	$102.3 - $112.62 $3,478 - $3,829	34 Added 0.67%	5,110 $553,000
Q4 2020 Jan 27, 2021	BUY	$80.49 - $108.67 $55,860 - $75,416	694 Added 15.84%	5,076 $544,000
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $22,937 - $26,921	267 Added 6.49%	4,382 $384,000
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $42,554 - $56,944	580 Added 16.41%	4,115 $404,000
Q1 2020 May 05, 2020	BUY	$64.5 - $97.79 $8,127 - $12,321	126 Added 3.7%	3,535 $269,000
Q4 2019 Jan 30, 2020	SELL	$72.13 - $90.25 $5,265 - $6,588	-73 Reduced 2.1%	3,409 $302,000
Q3 2019 Nov 06, 2019	SELL	$62.98 - $75.72 $20,090 - $24,154	-319 Reduced 8.39%	3,482 $264,000
Q2 2019 Jul 30, 2019	SELL	$65.7 - $83.98 $4,073 - $5,206	-62 Reduced 1.6%	3,801 $276,000
Q1 2019 Apr 23, 2019	SELL	$77.14 - $90.79 $7,482 - $8,806	-97 Reduced 2.45%	3,863 $311,000
Q4 2018 Jan 16, 2019	SELL	$77.85 - $96.01 $8,797 - $10,849	-113 Reduced 2.77%	3,960 $365,000
Q3 2018 Nov 09, 2018	BUY	$88.91 - $98.84 $177 - $197	2 Added 0.05%	4,073 $385,000
Q2 2018 Aug 01, 2018	BUY	$89.78 - $106.23 $179 - $212	2 Added 0.05%	4,071 $377,000
Q1 2018 Apr 27, 2018	BUY	$92.01 - $123.21 $184 - $246	2 Added 0.05%	4,069 $385,000
Q4 2017 Feb 07, 2018	BUY	$89.56 - $98.21 $364,240 - $399,420	4,067	4,067 $393,000

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $290B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.

Account

Carmichael Hill & Associates, Inc. Abb Vie Inc. Transaction History